ALNYLAM PHARMACEUTICALS, INC. Insider Trading for February 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALNYLAM PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ALNYLAM PHARMACEUTICALS, INC. for February 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 28 2020 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Option Exercise | A | 118.05 | 24,554 | 2,898,600 | 24,554 | |
| Feb 28 2020 | ALNY | ALNYLAM PHARMACEUT ... | Poulton Jeffrey V. | Chief Financial Off ... | Option Exercise | A | 118.05 | 24,554 | 2,898,600 | 24,554 | |
| Feb 28 2020 | ALNY | ALNYLAM PHARMACEUT ... | Poulton Jeffrey V. | Chief Financial Off ... | Buy | J | 0.00 | 19 | 0 | 19 | 0 to 19 |
| Feb 28 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | A | 118.05 | 27,623 | 3,260,895 | 27,623 | |
| Feb 28 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | A | 118.05 | 88,240 | 10,416,732 | 88,240 | |
| Feb 28 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Option Exercise | A | 118.05 | 29,925 | 3,532,646 | 29,925 | |
| Feb 28 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | Chief Operating Off ... | Option Exercise | A | 118.05 | 27,623 | 3,260,895 | 27,623 | |
| Feb 21 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 9.14 | 34,765 | 317,752 | 104,295 | |
| Feb 21 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 133.42 | 502 | 66,977 | 189,993 | 190.5 K to 190 K (-0.26 %) |
| Feb 21 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 132.81 | 18,065 | 2,399,213 | 190,495 | 208.6 K to 190.5 K (-8.66 %) |
| Feb 21 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 131.61 | 6,887 | 906,398 | 208,560 | 215.4 K to 208.6 K (-3.20 %) |
| Feb 21 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 131.07 | 5,053 | 662,297 | 215,447 | 220.5 K to 215.4 K (-2.29 %) |
| Feb 21 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 129.33 | 1,586 | 205,117 | 220,500 | 222.1 K to 220.5 K (-0.71 %) |
| Feb 21 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 128.62 | 2,672 | 343,673 | 222,086 | 224.8 K to 222.1 K (-1.19 %) |
| Feb 21 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 9.14 | 34,765 | 317,752 | 224,758 | 190 K to 224.8 K (+18.30 %) |
| Feb 12 2020 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Option Exercise | M | 77.40 | 10,000 | 774,000 | 52,000 | |
| Feb 12 2020 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Sell | S | 129.00 | 10,000 | 1,290,000 | 12,258 | 22.3 K to 12.3 K (-44.93 %) |
| Feb 12 2020 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Buy | M | 77.40 | 10,000 | 774,000 | 22,258 | 12.3 K to 22.3 K (+81.58 %) |
| Feb 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | PAUL STEVEN M | Director | Option Exercise | M | 14.67 | 30,000 | 440,100 | 0 | |
| Feb 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | PAUL STEVEN M | Director | Sell | S | 130.00 | 30,000 | 3,900,000 | 1,000 | 31 K to 1,000 (-96.77 %) |
| Feb 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | PAUL STEVEN M | Director | Buy | M | 14.67 | 30,000 | 440,100 | 31,000 | 1,000 to 31 K (+3,000.00 %) |
| Feb 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | M | 42.22 | 18,750 | 791,625 | 6,250 | |
| Feb 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | M | 42.22 | 4,000 | 168,880 | 21,000 | |
| Feb 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 125.00 | 23,708 | 2,963,500 | 11,215 | 34.9 K to 11.2 K (-67.89 %) |
| Feb 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Buy | M | 42.22 | 4,000 | 168,880 | 34,923 | 30.9 K to 34.9 K (+12.94 %) |
| Feb 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Buy | M | 42.22 | 18,750 | 791,625 | 30,923 | 12.2 K to 30.9 K (+154.03 %) |
| Feb 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | Chief Operating Off ... | Option Exercise | M | 42.22 | 5,600 | 236,432 | 6,900 | |
| Feb 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | Chief Operating Off ... | Option Exercise | M | 42.22 | 6,250 | 263,875 | 12,500 | |
| Feb 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | Chief Operating Off ... | Sell | S | 130.00 | 9,892 | 1,285,960 | 1,916 | 11.8 K to 1.9 K (-83.77 %) |
| Feb 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | Chief Operating Off ... | Buy | M | 42.22 | 5,600 | 236,432 | 11,808 | 6.2 K to 11.8 K (+90.21 %) |
| Feb 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | Chief Operating Off ... | Sell | S | 123.90 | 6,250 | 774,375 | 6,208 | 12.5 K to 6.2 K (-50.17 %) |
| Feb 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | Chief Operating Off ... | Buy | M | 42.22 | 6,250 | 263,875 | 12,458 | 6.2 K to 12.5 K (+100.68 %) |